Dr. Peter Stirling (Stirling Lab) received grant funding from the France Canada Research Fund for his research entitled “Developing splice-switching oligonucleotides to rewire splicing SF3B1-mutated myelodysplastic syndromes”.
The France Canada Research Fund is a major instrument of Franco-Canadian scientific cooperation, created in 2000 through an agreement between the French Embassy in Canada and a consortium of 16 Canadian universities.
In twenty years, the FCRF has financed over 300 collaborative research projects. The FCRF is currently made up of twenty member universities and supports around 20new projects each year. These projects are led by French and Canadian teams collaborating for the first time.
Congratulations Dr. Stirling!